期刊文献+

低分子量肝素减少局灶节段性肾小球硬化鼠足细胞的脱落 被引量:5

Low Molecular Weight Heparin Decrease Podocytes Detachment in Focal Segmental Glomerulosclerosis Rats
下载PDF
导出
摘要 目的观察整合素α3β1、α-肌营养不良蛋白聚糖(α-DG)在局灶节段性肾小球硬化(FSGS)大鼠肾小球的表达以及低分子量肝素(LMWH)对它们的影响。方法制备FSGS大鼠模型,随机将动物分为FSGS组、治疗组,另设对照组。治疗组给予LMWH410U.kg-1皮下注射,2次/d。8周后,检测各组24h尿蛋白定量(TP)、血清半胱氨酸蛋白酶抑制剂(CysC)、肾小球硬化指数(GSI);检测尿沉渣足细胞特异性标志蛋白podocalxin(PCX),尿PCX荧光细胞即为尿液足细胞(UPC);免疫荧光检测肾小球整合素α3β1、α-DG表达分布。分离肾小球,Western印迹法检测肾小球整合素α3β1、α-DG蛋白表达水平。光镜下观察肾组织病理改变。结果LMWH组TP、CysC、GSI以及病理改变较FSGS组明显改善。正常大鼠整合素α3β1、α-DG主要沿肾小球血管袢呈线性表达;FSGS组肾小球整合素α3β1、α-DG表达比对照组明显减弱;LMWH组整合素α3β1、α-DG表达较FSGS组明显增加。结论LMWH可以减少FSGS肾病大鼠尿蛋白,改善肾脏病理变化,保护肾功能。上调整合素α3β1、α-DG的表达,减少足细胞的脱落。 Aim To observe the effect of low molecular weight heparin (LMWH) on the expression of integnn α3β1 and α-dystroglycan(α-DG) in the glomeruli of focal segmental glomerulosclerosis(FSGS) rats. Methods SD rats were divided into three groups:normal rats, FSGS rats, FSGS rats treated with 410U·kg^-1 LMWH by subcutaneous injection twice a day for 8 weeks. 24-hour total proteinuria(TP), serum cystatin C(Cys C), glomerulosclerotic indexes (GSI) were measured. Podocyte-specific marker protein-podocalxin (PCX) was detected in urinary sediment and urinary PCX-positive cells were identified as UPC. The expression of integrin α3β1 and α-DG in glomeruli was determined by immunofluorescence and westernblot. In addition, the renal tissue pathology was observed by light microscopy. Results Compared to FSGS group, the levels of TP, CysC, GSI in LMWH treated group decreased significantly. Renal pathologic changes of the glomeruli in LMWH treated group were also improved. The expression of integrin α3β1 and α-DG was mainly distributed along glomerular vessels in a linear pattern. Compared to normal group, the expression of integrin α3β1 and α-DG decreased in glomeruli of FSGS rats. After g-week treatment, LMWH significantly up-regulated the expression of integrin α3β1 and α-DG compared to the FSGS rats. Conclusion LMWH can attenuate proteinuria, improves renal pathology,protects against renal function,decrease podocytes detachment and possibly by up-regulating the expression of integrin α3β1 and α-DG.
出处 《解放军药学学报》 CAS 2009年第1期1-4,共4页 Pharmaceutical Journal of Chinese People's Liberation Army
关键词 整合素Α3Β1 肾硬化症 低分子量肝素 足细胞 integrin α3β1 kidney sclerosis low molecular weight heparin podocyte
  • 相关文献

参考文献12

  • 1Mundel P, Shankland SJ. Podocyte biology and response to injury [J]. J Am Soc Nephrol ,2002,13(12) :3005
  • 2邹敏书,聂国明,余健.低分子量肝素对糖尿病大鼠肾组织的保护作用[J].中国药师,2007,10(9):855-857. 被引量:3
  • 3甘良英,于仲元,蔡美顺,赵慧萍,李欣.低分子质量肝素对糖尿病肾病大鼠肾血管内皮生长因子表达的影响[J].北京大学学报(医学版),2005,37(4):382-385. 被引量:7
  • 4Calkin AC, Giunti S, Jandeleit-Dahm KA, et al. PPAR-α and -γ agonists attenuate diabetic kidney disease in the apolipoprotein E knockout mouse [ J ]. Nephrol Dial Transplant , 2006,21 ( 9 ) : 2399
  • 5Nakamura T, Ushiyama C, Hirokawa K, et al. Effect of cerivastatin on proteinuria and urinary podocytes in patients with chronic glomerulonephritis [ J ]. Nephrol Dial Transplant ,2002,17 (5) :798
  • 6Regoli M, Bendayan M. Alterations in the expression of the alpha3 betal integrin in certain membrane domains of the glomerular epithetlial ceils (podocytes) in diabetes mellitus[J]. Diabetologia , 1997 ,40 : 15
  • 7陈立平,周巧玲,彭卫生,吴晓英.足细胞超微结构及其相关分子表达变化在糖尿病肾病发病中的作用[J].中南大学学报(医学版),2007,32(4):620-625. 被引量:21
  • 8Bjomson Granqvist A, Ebefors K, Saleem MA, et al. Podocyte proteoglyean synthesis is involved in the development of nephrotic syndrome [ J ]. Am J Physiol Renal Physiol ,2006,291 (4) : F722
  • 9Topham P, Barratt J, FeehaUy J. A spoonful of sugar helps the proteinuria go down [ J ]. Nephrol Dial Transplant , 2008,23 ( 3 ) : 813
  • 10Benck U, Haeckel S, Clorius JH, et al. Proteinuria-lowering effect of heparin therapy in diabetic nephropathy without affecting the renin-angiotensin-aldosterone system [ J ]. Clin J Am Soc Nephrol, 2007,2( 1 ) :58

二级参考文献53

共引文献32

同被引文献111

  • 1李慧敏,缪珩,蒋秀琴.维生素D_3对糖尿病大鼠肾脏的保护作用[J].中国临床康复,2005,9(3):123-125. 被引量:11
  • 2秦卫松,刘志红,曾彩虹,郑春霞,贾忠辉,王生余,黎磊石.雷公藤甲素对Heymann肾炎模型足细胞病变的影响[J].肾脏病与透析肾移植杂志,2007,16(2):101-109. 被引量:96
  • 3Mundel P,Shankland SJ.Podocyte biology and response to injury[J].J Am Soc Nephrol,2002,13(12):3005-3015.
  • 4Agarwal R,Acharya M,Tian J,et al.Antiproteinuric effect of oral paricalcitol in chronic kidney disease[J].Kidney Int,2005,68(6):2823-2828.
  • 5Kuhlmann A,Haas CS,Gross ML,et al.1,25-Dihydroxyvitamin D3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat[J].Am J Physiol Renal Physiol,2004,286(3):F526-F533.
  • 6Kelly DJ,Chanty A,Gow RM,et al.Protein kinase C beta inhibition attenuates osteopontin expression,macrophage recruitment,and tubulointerstitial injury in advanced experimental diabetic nephropathy[J].J Am Soc Nephrol,2005,16(6):1654-1660.
  • 7Sharma R,Khanna A,Sharma A,et al.Transforming growth factor-β1 increases albumin permeability of isolated rat glomeruli via hydroxyl radicals[J].Kidney Int,2000,58(1):131-136.
  • 8Ding G,Reddy K,Kapasi AA,et al.Angiotensin II induces apoptosis in rat glomerular epithelial cells[J].Am J Physiol Renal Physiol,2002,283(1):F173-F180.
  • 9Tan X,Li Y,Liu Y.Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy[J].J Am Soc Nephrol,2006,17(12):3382-3393.
  • 10Schwarz U,Amann K,Orth SR,et al.Effect of 1,25(OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats[J].Kidney Int,1998,53(6):1696-1705.

引证文献5

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部